Scarica l'app Stockscreener
8.96
3.94%
0.34
Dopo l'orario di chiusura:
8.92
-0.04
-0.45%
Precedente Chiudi:
$8.62
Aprire:
$8.62
Volume 24 ore:
2.08M
Relative Volume:
0.85
Capitalizzazione di mercato:
$885.48M
Reddito:
-
Utile/perdita netta:
$-44.84M
Rapporto P/E:
-19.06
EPS:
-0.47
Flusso di cassa netto:
$-44.23M
1 W Prestazione:
-1.65%
1M Prestazione:
-10.85%
6M Prestazione:
-35.86%
1 anno Prestazione:
-39.13%
Intervallo 1D:
$8.4517
$8.98
Intervallo di 1 settimana:
$8.4517
$9.655
Portata 52W:
$8.4517
$18.90
Ars Pharmaceuticals Inc Stock (SPRY) Company Profile
Nome
Ars Pharmaceuticals Inc
Settore
Industria
Telefono
858-771-9307
Indirizzo
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
Confronta SPRY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRY
Ars Pharmaceuticals Inc
|
8.96 | 851.88M | 0 | -44.84M | -44.23M | -0.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ars Pharmaceuticals Inc Stock (SPRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Iniziato | Roth Capital | Buy |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-10 | Iniziato | Oppenheimer | Outperform |
| 2024-08-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-08-12 | Reiterato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | Raymond James | Outperform |
| 2024-03-05 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-02-20 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-09-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Iniziato | Wedbush | Outperform |
| 2023-01-03 | Iniziato | William Blair | Outperform |
| 2022-12-13 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Ars Pharmaceuticals Inc Borsa (SPRY) Ultime notizie
Why ARS Pharmaceuticals Inc. stock could outperform in 2025Weekly Risk Summary & Daily Price Action Insights - newser.com
Why ARS Pharmaceuticals Inc. stock is recommended by analystsTrade Volume Summary & Growth Focused Investment Plans - newser.com
Published on: 2025-11-02 04:08:25 - newser.com
Will ARS Pharmaceuticals Inc. rebound enough to break evenGap Down & Advanced Swing Trade Entry Alerts - newser.com
Custom strategy builders for tracking ARS Pharmaceuticals Inc.Quarterly Profit Report & Free Technical Pattern Based Buy Signals - newser.com
Multi factor analysis applied to ARS Pharmaceuticals Inc.Earnings Recap Report & Expert Approved Momentum Trade Ideas - newser.com
How ARS Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 Outlook & Precise Trade Entry Recommendations - newser.com
Why ARS Pharmaceuticals Inc. stock could rally in 2025Trade Entry Summary & Reliable Volume Spike Trade Alerts - newser.com
How ARS Pharmaceuticals Inc. stock trades during market volatilityGap Up & Daily Oversold Bounce Ideas - newser.com
Published on: 2025-11-01 01:27:58 - newser.com
ARS Pharmaceuticals (NASDAQ:SPRY) Hits New 52-Week LowWhat's Next? - MarketBeat
How ARS Pharmaceuticals Inc. stock valuations compare to rivalsWeekly Stock Recap & Low Drawdown Investment Ideas - newser.com
Trend analysis for ARS Pharmaceuticals Inc. this weekMarket Weekly Review & Momentum Based Trading Ideas - newser.com
Reversal indicators forming on ARS Pharmaceuticals Inc. stockWeekly Stock Summary & High Accuracy Investment Entry Signals - newser.com
Is ARS Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com
Is ARS Pharmaceuticals Inc. a candidate for recovery playWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
ARS Pharmaceuticals Hits New 52-Week Low at $8.90 Amid Financial Struggles - Markets Mojo
Ars Pharmaceuticals’ Latest Study: A Potential Game-Changer in Allergy Treatment - MSN
Can ARS Pharmaceuticals Inc. stock sustain revenue growthWeekly Stock Summary & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará
Allianz Asset Management GmbH Makes New $639,000 Investment in ARS Pharmaceuticals, Inc. $SPRY - MarketBeat
How ARS Pharmaceuticals Inc. stock performs in rate cut cycles2025 Trading Recap & Fast Entry Momentum Trade Alerts - fcp.pa.gov.br
Ars Pharmaceuticals Inc Azioni (SPRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):